Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Department of Paediatrics, University of Cambridge, Cambridge, CB2 0QQ, UK.
Nat Commun. 2022 Jul 8;13(1):3949. doi: 10.1038/s41467-022-31341-0.
Cellular DNA damage caused by reactive oxygen species is repaired by the base excision repair (BER) pathway which includes the DNA glycosylase MUTYH. Inherited biallelic MUTYH mutations cause predisposition to colorectal adenomas and carcinoma. However, the mechanistic progression from germline MUTYH mutations to MUTYH-Associated Polyposis (MAP) is incompletely understood. Here, we sequence normal tissue DNAs from 10 individuals with MAP. Somatic base substitution mutation rates in intestinal epithelial cells were elevated 2 to 4-fold in all individuals, except for one showing a 31-fold increase, and were also increased in other tissues. The increased mutation burdens were of multiple mutational signatures characterised by C > A changes. Different mutation rates and signatures between individuals are likely due to different MUTYH mutations or additional inherited mutations in other BER pathway genes. The elevated base substitution rate in normal cells likely accounts for the predisposition to neoplasia in MAP. Despite ubiquitously elevated mutation rates, individuals with MAP do not display overt evidence of premature ageing. Thus, accumulation of somatic mutations may not be sufficient to cause the global organismal functional decline of ageing.
活性氧引起的细胞 DNA 损伤可通过碱基切除修复 (BER) 途径修复,该途径包括 DNA 糖苷酶 MUTYH。遗传的双等位 MUTYH 突变可导致结直肠腺瘤和癌的易感性。然而,从种系 MUTYH 突变到 MUTYH 相关息肉病 (MAP) 的机制进展尚不完全清楚。在这里,我们对 10 名 MAP 患者的正常组织 DNA 进行了测序。除了一个个体的突变率增加了 31 倍外,所有个体的肠上皮细胞中的体细胞碱基取代突变率均升高了 2 到 4 倍,其他组织中的突变率也升高了。增加的突变负担具有多种突变特征,其特征是 C> A 变化。个体之间不同的突变率和特征可能是由于不同的 MUTYH 突变或其他 BER 途径基因的遗传突变。正常细胞中碱基取代率的升高可能导致 MAP 中肿瘤易感性的增加。尽管突变率普遍升高,但 MAP 患者并未表现出明显的衰老迹象。因此,体细胞突变的积累可能不足以导致衰老导致的全身器官功能下降。
Biochem Soc Trans. 2005-8
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007-7
Ned Tijdschr Geneeskd. 2005-12-31
J Pathol. 2017-12-14
Nat Rev Cancer. 2025-8-26
JCI Insight. 2025-5-13
bioRxiv. 2025-3-6
Hered Cancer Clin Pract. 2025-1-23
Nat Commun. 2024-12-23
Signal Transduct Target Ther. 2024-10-7
Gastroenterology. 2021-2
Cell. 2020-8-6
Nature. 2020-4-22